Matches in DBpedia 2016-04 for { ?s ?p "Vayarol is an orally administered prescription medical food for the dietary management of hypertriglyceridemia . Vayarol contains Lipirolen™, a proprietary composition containing Phytosterol Esters of Omega-3 which was developed by VAYA Pharma (division of Enzymotec LTD), a specialty pharmaceutical company. The VAYA Pharma portfolio addresses three therapeutic segments: ADHD (Vayarin), Hypertriglyceridemia (Vayarol) and Memory impairment (Vayacog). Vayarol is regulated by the U.S. Food and Drug Administration (FDA) under the Orphan Drug Act and is intended for the distinct nutritional requirements of hypertriglyceridemic patients."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Vayarol abstract "Vayarol is an orally administered prescription medical food for the dietary management of hypertriglyceridemia . Vayarol contains Lipirolen™, a proprietary composition containing Phytosterol Esters of Omega-3 which was developed by VAYA Pharma (division of Enzymotec LTD), a specialty pharmaceutical company. The VAYA Pharma portfolio addresses three therapeutic segments: ADHD (Vayarin), Hypertriglyceridemia (Vayarol) and Memory impairment (Vayacog). Vayarol is regulated by the U.S. Food and Drug Administration (FDA) under the Orphan Drug Act and is intended for the distinct nutritional requirements of hypertriglyceridemic patients.".
- Q17088448 abstract "Vayarol is an orally administered prescription medical food for the dietary management of hypertriglyceridemia . Vayarol contains Lipirolen™, a proprietary composition containing Phytosterol Esters of Omega-3 which was developed by VAYA Pharma (division of Enzymotec LTD), a specialty pharmaceutical company. The VAYA Pharma portfolio addresses three therapeutic segments: ADHD (Vayarin), Hypertriglyceridemia (Vayarol) and Memory impairment (Vayacog). Vayarol is regulated by the U.S. Food and Drug Administration (FDA) under the Orphan Drug Act and is intended for the distinct nutritional requirements of hypertriglyceridemic patients.".